* Axonics Inc AXNX.OQ reported quarterly breakeven
results per
share for the quarter ended September 30, lower than the same
quarter last year, when the company reported EPS of 8 cents.
The mean expectation of twelve analysts for the quarter was
for earnings of 13 cents per share. Wall Street expected
results to range from 4 cents to 20 cents per share.
* Revenue rose 24.8% to $116.19 million from a year ago;
analysts
expected $113.50 million.
* Axonics Inc's reported EPS for the quarter was breakeven
results.
* The company reported a quarterly loss of $21 thousand.
* Axonics Inc shares had risen by 1.2% this quarter and
gained 13.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 17.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 12
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"
Wall Street's median 12-month price target for Axonics Inc is
71.00
This summary was machine generated from LSEG data November 8 at
04:31 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.13 0.00 Missed
Jun. 30 2024 0.13 0.13 Met
Mar. 31 2024 -0.08 -0.27 Missed
Dec. 31 2023 0.06 0.13 Beat